York Space Systems (YSS): The Broken IPO That Owns the Pentagon's Most Critical Satellite Program

Initiating Coverage | Hawkmont Research | April 2026

HAWKMONT RESEARCH | EQUITY RESEARCH | NATIONAL SECURITY SPACE

The most important satellite manufacturing program in U.S. defense history has one company that has won every tranche. That company just went public at $34 and trades at $22.

Rating: Neutral (Hold) | Price Target: $28 | Current Price: ~$22 | Ticker: NYSE: YSS

---

Investment Thesis

York Space Systems is the dominant prime contractor for the Space Development Agency's Proliferated Warfighter Space Architecture (PWSA) - the U.S. military's most ambitious satellite program since GPS. York has won across Tranches 0, 1, and 2, claims an 83% win rate on PWSA bids, and has delivered more satellites to the program than any other vendor. It just completed its IPO at $34 per share in January 2026 and promptly sold off 35% to ~$22.

That selloff is not irrational. It reflects a set of structural risks that are real, not imagined: ~95% of revenue from a single government customer, fixed-price contracts that have already caused one ugly margin implosion, a backlog burning faster than new awards are coming in, and a PE sponsor sitting on a majority position with a lock-up clock ticking.

But it also creates an entry point worth analyzing seriously. The core question for any investor in YSS is simple: does York win a meaningful share of Tranche 3 Transport Layer and deliver on its FY2026 EBITDA guidance? If yes, this stock re-rates materially from here. If no, there is credible downside to $12.

We initiate coverage with a Neutral (Hold) rating and a 12-month price target of $28, representing approximately 27% upside from current levels. That is insufficient risk-adjusted upside given the binary nature of the near-term catalysts. We would become constructive buyers on evidence of: a T3 Transport Layer award of $200M+, Q1/Q2 2026 gross margin above 20%, or a book-to-bill above 1.2x.

---

Key Financial and Operating Metrics

Metric	Value	Notes
Stock Price (Apr 2026)	~$22.00	NYSE: YSS
Market Capitalization	~$2.8B	Post-IPO float
IPO Price (Jan 29, 2026)	$34.00	Priced at top of range
52-Week Range	$16.93 – $38.47	Broken IPO; declined day 1
FY2025 Revenue	$386.2M	+52% YoY
FY2026 Revenue Guidance	$545–$595M	Management guided; +41–54%
FY2025 Gross Margin	~19.5%	Recovered from 13% in FY2024
FY2025 Adj. EBITDA	–$8.3M	vs. –$43M in FY2024
FY2025 Net Loss	–$84.5M	Narrowed from –$98.9M
Backlog (YE 2025)	~$543M	Down from $861.7M at end-2024
Post-IPO Liquidity	~$895M	Cash + facilities
Employees	670+	Denver, CO HQ
EV / Fwd Revenue	~4.8x	On FY2026 midpoint guide
Hawkmont Price Target	$28.00	12-month; Hold

Company Overview

York Space Systems, Inc. is a Denver-based national security space company founded in 2012 by CEO Dirk Wallinger. It designs, manufactures, integrates, tests, and operates satellites for the U.S. government - primarily the Space Development Agency's PWSA constellation. York went public on the NYSE on January 29, 2026, raising $582.6M in its IPO. AE Industrial Partners, which acquired its majority stake in 2022, remains the controlling shareholder post-offering.

The company operates a 60,000-square-foot manufacturing and testing facility in Potomac, Colorado, designed to support production of more than 1,000 satellites annually - a number that sounds speculative until you realize the PWSA programme calls for hundreds of satellites across multiple tranches through the early 2030s.

York's 2025 acquisitions of ATLAS Space Operations (ground infrastructure) and Orbion Space Technology (propulsion) signal an intent to capture more of the satellite lifecycle and reduce dependence on the single bus-manufacturing revenue line. Neither acquisition is yet a material revenue contributor.

Business Model

York's revenue engine has one primary gear: fixed-price satellite bus manufacturing contracts for the SDA. Everything else - software, antennas, ground operations, data services - is a rounding error today and an aspiration for 2027 and beyond.

How the money flows: York wins a PWSA tranche award, builds satellites to SDA specifications at its Potomac facility, delivers them to launch, and recognizes revenue as milestones are met. Because contracts are firm-fixed-price, every dollar of cost overrun is York's problem, not the government's. This creates a structural incentive for manufacturing efficiency - and a structural risk when program complexity is underestimated.

Platform strategy: York's S-CLASS bus is the workhorse of the current backlog. The company introduced the M-CLASS platform in 2025 to support higher-power payloads and broader mission types. The M-CLASS is important because it opens York to tracking layer and missile defense payloads - historically dominated by larger primes - and is the platform most relevant to any Golden Dome opportunity.

Revenue mix: In the first nine months of 2025, government customers drove $270M in revenue. Commercial was $11M. That ratio is the single most important number in the York investment case - and not in a good way.

Revenue and Margin History

Period	Revenue	YoY Growth	Gross Margin	Net Loss
FY2023	$238.1M	-	~23%	–$29.7M
FY2024	$253.5M	+6%	13%	–$98.9M
FY2025	$386.2M	+52%	~19.5%	–$84.5M
FY2026E	$545–595M	+41–54%	~22%+ (mgmt)	Approaching breakeven

The margin trajectory is the central narrative tension of this investment. The collapse from 23% to 13% in FY2024 was driven by estimate-at-completion (EAC) adjustments on in-flight programs - engineering shorthand for "we underpriced the contract and now we're eating the difference." The recovery to 19.5% in FY2025 is real. The question every investor must ask is whether that recovery reflects durable operational improvement or favorable program mix that normalizes in 2026.

Management claims the improvement is structural, driven by manufacturing efficiency gains at Potomac, better cost visibility on new awards, and the maturation of the S-CLASS production line. We are cautious. EAC adjustments are a recurring feature of fixed-price government contracting, not a one-time event, and York's track record is a single public year.

Industry Structure and Market Context

The PWSA is the defining U.S. national security space program of the 2020s. The constellation is designed to provide persistent global communications, missile warning, and kill-chain connectivity across LEO. The Space Force has a projected $37B FY2026 budget and approximately $175B in total multi-year spend, with PWSA as the anchor program.

York has won prime positions across Tranches 0, 1, and 2 of the Transport Layer - the data relay backbone of the constellation. The programme calls for hundreds of additional satellites across T3 and T4, meaning the total contract runway available to York (and its competitors) over the next decade is substantial.

What the competition looks like:

Company	Role in PWSA	Key Advantage
York Space Systems	T0/T1/T2 Transport Layer prime	Cost, delivery speed, incumbency
Rocket Lab (RKLB)	T3 Tracking Layer prime ($816M)	Vertical integration, launch access
Northrop Grumman	T1/T2 Transport + T3 Tracking	Scale, sensor expertise
Lockheed Martin	T2 Beta + T3 Tracking ($1.1B)	Balance sheet, systems integration
L3Harris	T3 Tracking ($843M)	Payload / sensor capability
Terran Orbital (LMT sub)	T2 Gamma subcontract	Lockheed backstop

The most important competitive data point for YSS investors is not what York has won - it is what York did not win. The T3 Tracking Layer awards announced in December 2025 ($3.5B across four vendors) went to Lockheed, L3Harris, Northrop, and Rocket Lab. York was not among them. This is not a disaster - York's history is the Transport Layer, not the Tracking Layer - but it illustrates that the SDA is comfortable diversifying its vendor pool for higher-complexity payloads, and that York's incumbency advantage does not automatically translate across mission types.

The Golden Dome programme - the Trump administration's proposed national missile defense architecture - is the next major potential opportunity. York has demonstrated two capabilities it believes are prerequisites for Golden Dome prime positions: Link-16 connectivity from space (a first) and LEO-to-LEO laser links. Whether these translate into contract awards is unknown; the programme is nascent and the procurement timeline is unclear.

Competitive Advantage: What Is Real, What Is Fragile

Real:

York's manufacturing throughput advantage is documented, not theoretical. Delivering more satellites to PWSA than any other vendor across three tranches is a genuine operational reference. The Potomac facility's vertical integration - manufacturing, assembly, integration, and testing under one roof - reduces schedule risk relative to distributed supply chain models. The claim that York builds satellites at roughly half the per-unit cost of competitors is backed by the SDA's own procurement behavior: York keeps winning bids.

York also holds two meaningful technical firsts: the first LEO-to-LEO laser link between PWSA vendors, and the first demonstration of Link-16 connectivity from space. These are not marketing claims - they are milestones cited in the company's 10-K as differentiating factors for Golden Dome competition.

Fragile:

The moat is thin above the transport layer. York's competitive position in satellite bus manufacturing for communications relay is strong. Its competitive position in higher-complexity payloads - infrared missile warning sensors, advanced tracking systems - is unproven. Rocket Lab's $816M T3 Tracking Layer award demonstrates that a well-capitalized, vertically integrated competitor with launch access is aggressively moving up the complexity curve.

Pricing power is structurally limited. Fixed-price contracts mean York competes on cost, full stop. The government will re-compete every tranche. The incumbent discount (faster award cycles, fewer qualification risks) is real but not infinite.

Financial Analysis: The Path to EBITDA Positive

The operating leverage story is the most credible part of the bull case. SG&A and R&D grew only 8% in FY2025 against 52% revenue growth. That is genuine operating leverage, not financial engineering. If the FY2026 revenue guide of $545–595M materialises and gross margins hold near 20%, the math to positive adjusted EBITDA closes quickly.

FY2026 Base Case Path:

Item	Estimate
Revenue	~$570M (midpoint guide)
Gross Margin	~20% = ~$114M gross profit
SG&A + R&D	~$120M (assume continued discipline)
Adj. EBITDA	~$0 to +$15M
Net Income	Still negative (D&A, interest)

The cash position is adequate but not comfortable. Post-IPO liquidity of ~$895M sounds strong, but operating cash outflow in the nine months ended September 2025 was $88.2M - driven by working capital intensity as accounts receivable expanded sharply against declining cash. The IPO proceeds provide a 12–18 month runway for working capital before the company must demonstrate EBITDA conversion.

Backlog: The Burn Rate Problem

Backlog declined from $861.7M at end-2024 to approximately $543M at year-end 2025. That $318M decline represents revenue recognised outpacing new awards. The FY2026 revenue guide of $545–595M (with management noting >70% coverage from existing backlog) implies approximately $160–200M in new awards needed in 2026 to maintain the trajectory into 2027. A book-to-bill below 1x for more than two consecutive quarters would be a materially negative signal.

Key Catalysts and Timeline

Timeline	Catalyst	Potential Impact	Probability
Q2 2026	T3 Transport Layer contract award	Very High - sets 2027–2029 backlog	Medium-High
Q1–Q2 2026	First public earnings (Q1/Q2 2026)	High - gross margin visibility	Certain
2026 Ongoing	Golden Dome programme award decisions	Transformative if won	Low-Medium
Mid-2026	Book-to-bill signal from new contract flow	High - backlog health indicator	Medium
H2 2026	ATLAS + Orbion revenue contribution	Moderate - customer diversification proof	Medium
2026–2027	AE Industrial Partners lock-up expiry	Technical overhang, likely headwind	High
FY2026	Positive adj. EBITDA delivery	De-risking; re-rating catalyst	Medium

Risk Factors

Critical Risks:

Customer concentration. Approximately 95% of revenue from one customer (SDA) with approximately 86% of receivables tied to that customer as of September 30, 2025. There is no diversification hedge. A funding freeze, programme restructure, or competitive loss on any major tranche would flow directly to the P&L with nothing to offset it.

Fixed-price contract risk. FY2024's gross margin collapse from 23% to 13% was caused by EAC adjustments - cost overruns on fixed-price programs absorbed entirely by York. This is not a one-time risk. Every new tranche award carries the same structural exposure. Program complexity tends to increase with each tranche, not decrease.

Backlog burn rate. Book-to-bill below 1x through most of 2025 means York is consuming backlog faster than it is replacing it. The FY2026 guide requires meaningful new award wins. If the T3 Transport Layer award is delayed or smaller than expected, the 2027 revenue trajectory becomes uncertain.

Sponsor overhang. AE Industrial Partners retains majority control. Lock-up expiration creates a predictable supply overhang event. PE sponsors exit on their schedule, not the market's.

Internal control weakness. The 10-K disclosed a material weakness in internal controls. This is a significant flag for a newly public company in its first reporting year, and remediation requires management attention that would otherwise go to operational execution.

Competitive displacement. Rocket Lab's vertical integration (launch + spacecraft) is a structural advantage York cannot replicate. RKLB's aggressive bidding on tracking layer and missile defense payloads - backed by its own launch economics - positions it as the most credible long-term competitive threat in the government space systems market.

Valuation Perspective

At approximately $22 per share and a market cap of roughly $2.8B, YSS trades at approximately 4.8x forward revenue on the FY2026 midpoint guide of $570M.

The valuation debate is fundamentally about peer group selection:

Comparator	Forward P/S	Rationale
YSS (current)	~4.8x	Broken IPO discount
Rocket Lab (RKLB)	~11–13x	Vertical integration premium, faster growth
High-growth space peers	~11.3x (avg)	Growth premium
U.S. A&D sector (broad)	~2–3x	Profitability premium
Hawkmont Base Case	~6–7x	Blended; assumes EBITDA delivery

We believe a blended framework is most appropriate. York's 52% revenue growth and path to EBITDA justify a premium to legacy defence contractors. Its single-customer concentration, fixed-price exposure, and negative free cash flow justify a meaningful discount to high-growth space peers.

At 6x forward revenue on the FY2026 midpoint ($570M), the implied market cap is approximately $3.4B, or roughly $27–28 per share on a diluted basis. That is our 12-month price target.

Bull Case - $38–42 (12 months)

York wins a T3 Transport Layer award of $250M+ and a preliminary Golden Dome position. FY2026 delivers $590M+ revenue with 22%+ gross margin and adj. EBITDA of $25–35M. Commercial revenue reaches $40–50M, improving concentration optics. Market re-rates to 7.5x forward revenue. Probability: 25%.

Bear Case - $10–14 (12 months)

T3 TL award is small or delayed into 2027. EAC adjustments compress FY2026 gross margin back to 14–16%. Revenue guide is missed at $480–510M. Book-to-bill falls below 0.8x for two consecutive quarters. AE Industrial lock-up expiry adds selling pressure. Market derates to 3x forward revenue. A dilutive equity raise - not our base case, but possible - would push further downside. Probability: 30%.

Base Case - $26–30 (12 months)

York wins a moderate T3 TL award ($150–200M), FY2026 revenue delivers near the midpoint ($555–575M), gross margin holds at 19–21%, and adj. EBITDA turns marginally positive. Market re-rates modestly to 5.5–6x forward revenue. Probability: 45%.

Conclusion and Rating

York Space Systems is a real business doing genuinely important work at the centre of U.S. national security space. Its manufacturing credentials are earned, its incumbency advantage is documented, and its margin recovery in 2025 is a positive operational signal. The IPO selloff has brought the valuation down from a level that required perfection to a level that requires only competent execution.

The problem is that "competent execution" in this business means: no EAC blowups on fixed-price contracts, winning competitive rebids on a programme the government controls and can restructure, maintaining the favour of a single customer that accounts for 95% of revenue, and doing all of this while transitioning from PE-backed private company to public company with a freshly disclosed material weakness in internal controls.

The risk-reward at $22 is more interesting than it was at $34. It is not yet compelling. The T3 Transport Layer award and the next two quarters of gross margin data will determine whether this is a $12 stock or a $40 stock. We want to see evidence before taking a position.

Rating: Neutral (Hold). 12-month price target: $28.

Upgrade triggers: T3 TL award $200M+, gross margin >20% sustained through H1 2026, book-to-bill >1.2x. Downgrade triggers: Revenue guide revision, EAC adjustment disclosure, T3 TL contract loss, dilutive equity raise.

---

Disclaimer: This report has been prepared by Hawkmont Research for informational and research purposes only. It does not constitute investment advice, a solicitation to buy or sell securities, or a recommendation of any specific investment action. All figures, prices, and data are approximate and based on publicly available information as of April 2026, including YSS SEC filings (S-1, 10-K), company press releases, and third-party financial data providers. Past performance is not indicative of future results. Investing in equities involves substantial risk, including the possible loss of principal. Hawkmont Research and its affiliates may hold positions in the securities discussed. Recipients of this report are responsible for conducting their own independent due diligence prior to making any investment decisions.